Transplant Immunology
Scope & Guideline
Unveiling the Complexities of Immunological Mechanisms in Transplantation.
Introduction
Aims and Scopes
- Transplant Rejection Mechanisms:
The journal explores the cellular and molecular mechanisms underlying both acute and chronic rejection in solid organ and hematopoietic stem cell transplants, providing insights into immune responses and their modulation. - Immunosuppressive Strategies:
Research on various immunosuppressive regimens, including the efficacy and safety of novel agents, is a core focus. The journal evaluates the impact of these therapies on transplant outcomes and patient survival. - Infection and Immunity:
The relationship between infections, particularly viral infections like CMV and COVID-19, and their effects on transplant recipients' immune response is a significant area of investigation. - Biomarkers and Diagnostics:
The identification and validation of biomarkers for predicting transplant outcomes, rejection, and complications are emphasized, aiding in the development of personalized medicine approaches. - Cell Therapy and Regenerative Medicine:
The application of stem cell therapies and regenerative medicine techniques in improving transplant outcomes and managing rejection is increasingly featured in the journal. - Ethical and Societal Issues in Transplantation:
The journal also addresses ethical considerations and societal impacts of organ transplantation, including donor-recipient matching, allocation policies, and public perceptions.
Trending and Emerging
- COVID-19 and Transplantation:
The impact of COVID-19 on transplant recipients, including vaccination responses and infection management, has become a prominent theme, reflecting the pandemic's influence on healthcare. - Machine Learning and Bioinformatics:
The integration of machine learning and bioinformatics in predicting transplant outcomes and personalizing immunosuppressive therapy is gaining traction, indicating a shift towards data-driven approaches in transplantation. - Microbiome and Immune Interactions:
Research exploring the role of the gut microbiome in modulating immune responses in transplant recipients is emerging, highlighting the importance of microbial health in transplantation. - Cell-Based Therapies:
The use of cell-based therapies, particularly involving mesenchymal stem cells and regulatory T cells, is increasingly featured, indicating a growing interest in regenerative approaches to manage rejection. - Longitudinal Studies and Real-World Data:
There is a rising emphasis on longitudinal studies and the use of real-world data to assess long-term outcomes and complications post-transplantation, providing a more comprehensive understanding of transplant success.
Declining or Waning
- Traditional Immunosuppressive Agents:
Research focusing solely on traditional immunosuppressive agents like calcineurin inhibitors has seen a decline as newer, more targeted therapies gain interest and application in clinical settings. - Generalized Risk Factors for Rejection:
While risk factors for transplant rejection remain important, the focus has shifted towards more specific biomarkers and mechanistic studies rather than broad, generalized factors. - Descriptive Case Reports:
While case reports are valuable, there is a noticeable decrease in the publication of purely descriptive case reports, with a preference for studies that provide mechanistic insights or larger cohort analyses.
Similar Journals
AMERICAN JOURNAL OF TRANSPLANTATION
Exploring breakthroughs in organ transplantation and immunology.American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.
Transplantation and Cellular Therapy
Connecting Science and Practice in Transplantation and Immunology.Transplantation and Cellular Therapy is a leading journal published by Elsevier Science Inc, dedicated to advancing the fields of transplantation, immunology, cell biology, and molecular medicine. With its ISSN of 2666-6375 and E-ISSN 2666-6367, this journal serves as a vital resource for researchers, practitioners, and students aiming to stay at the forefront of innovative therapies and clinical practices in transplantation. As of 2023, it holds an impressive Q1 ranking in multiple categories, including Cell Biology, Hematology, Immunology and Allergy, Molecular Medicine, and Transplantation, reflecting its high impact and relevance in the scientific community. The journal, operating from its base in the Netherlands, supports Open Access publishing to enhance the dissemination and accessibility of groundbreaking research. Acknowledging the significance of transplantation and cellular therapies in modern medicine, Transplantation and Cellular Therapy is poised to propel future discoveries and developments in these critical domains.
TRANSPLANTATION
Uncovering Insights for a Brighter Transplant Future.TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.
OncoImmunology
Advancing Cancer Care Through Immune InsightsOncoImmunology is a leading peer-reviewed journal published by Taylor & Francis Inc, dedicated to advancing the understanding of the dynamic interplay between the immune system and cancer. Established in 2012 and adopting an open access model since 2020, OncoImmunology provides a platform for high-quality research disseminated globally, with a notable focus on innovative therapies and immunotherapeutic strategies aimed at improving patient outcomes. The journal boasts an impressive impact in the field, holding Q1 rankings in both Immunology and Oncology categories for 2023, and it is recognized within the top-tier journals in its domain, reflected in its Scopus ranks and percentiles. With contributions from leading experts and a wide audience of researchers, clinicians, and advanced students, OncoImmunology not only facilitates scholarly dialogue but also addresses pivotal challenges in cancer treatment, making it an essential resource for those invested in the future of oncological and immunological research.
Transplantation Reviews
Advancing transplantation science through cutting-edge research.Transplantation Reviews is a premier scholarly journal published by Elsevier Science Inc, dedicated to advancing the field of transplantation and surgery. With an impressive impact factor and categorized in the top quartile (Q1) for both Surgery and Transplantation as of 2023, this journal prominently ranks in the 96th and 86th percentiles for its respective disciplines. Since its inception in 1987, it has provided a vital platform for researchers and professionals to disseminate high-quality, peer-reviewed articles that reflect the latest advancements and challenges in transplantation science. Although the journal is not currently open access, it remains a key resource for academic libraries and institutions. By fostering discussions and providing insights into clinical practices, Transplantation Reviews serves to enhance understanding and improve outcomes in the ever-evolving field of transplantation, making it an essential read for anyone engaged in this dynamic area of medicine.
Transplant Infectious Disease
Innovating solutions for safer transplant outcomes through infectious disease research.Transplant Infectious Disease is a premier journal dedicated to advancing the understanding of infectious complications in transplant recipients, contributing significantly to the fields of Infectious Diseases and Transplantation. Published by Wiley in the United Kingdom, this journal boasts an impressive reputation within the academic community, holding a 2023 Q2 quartile ranking in both Infectious Diseases and Transplantation, as well as notable Scopus rankings that position it among the top tiers of its categories. With a convergence of scholarly articles and research findings from 1999 through 2024, Transplant Infectious Disease serves as a critical resource for researchers, professionals, and students seeking to explore the intersection of transplantation and infectious diseases. The journal encourages open dialogue and knowledge dissemination through rigorous peer-reviewed content, making it an essential platform for those aiming to address the challenges and innovations in transplant medicine.
Journal of Transplantation
Fostering Collaboration in Transplantation ExcellenceThe Journal of Transplantation is a leading peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of organ transplantation and associated medical research. Since its inception in 2009 as an Open Access journal, it has provided a vital platform for researchers, clinicians, and students to share innovative findings and developments in transplantation science. With an emphasis on high-quality research, the journal aims to publish original articles, reviews, and case studies that contribute to the understanding of immunology, surgical techniques, and postoperative care, thereby enhancing patient outcomes. The journal is committed to fostering a collaborative scientific community and making valuable research freely accessible to professionals worldwide, ensuring that it remains at the forefront of transplantation studies. This journal serves as an essential resource for anyone looking to stay updated on the latest advancements and clinical practices in the field.
Transplantation Direct
Pioneering Open Access Solutions in Transplantation ScienceTransplantation Direct is a leading open access journal in the field of transplantation, published by the prestigious Lippincott Williams & Wilkins. Since its inception in 2015, the journal has provided a vital platform for the dissemination of high-quality research and advancements related to organ transplantation. With an impact factor that places it in the Q2 category among transplantation journals, it ranks #22 out of 54 in the Medicine - Transplantation Scopus classification, reflecting its significance and authority within the discipline. The journal not only covers a broad scope of topics related to transplantation but also encourages global collaboration and knowledge exchange amongst researchers, clinicians, and students. With its open access model, Transplantation Direct ensures that groundbreaking findings are accessible to a wider audience, fostering innovation and enhancing patient care worldwide. For more information, visit their address at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103.
HUMAN IMMUNOLOGY
Elevating Understanding of Immune MechanismsHUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.
ImmunoTargets and Therapy
Championing Open Access to Immunology InsightsImmunoTargets and Therapy is a leading open access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of immunology and its various therapeutic applications. Since its inception in 2012, the journal has rapidly become a vital resource for researchers, professionals, and students, achieving notable recognition with a Q1 ranking in both Immunology and Immunology and Allergy categories as of 2023. With an impressive Scopus ranking of #22 out of 233 in Medicine - Immunology and Allergy, and #25 out of 236 in Immunology and Microbiology, this journal maintains a 90th percentile standing in its field. ImmunoTargets and Therapy not only publishes original research articles, reviews, and clinical studies, but also fosters an inclusive platform for the dissemination of innovative findings critical to the fight against immunological disorders. Based in New Zealand, it serves a global audience, promoting knowledge exchange and collaboration through its open access model.